We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pfizer Inc | LSE:0Q1N | London | Ordinary Share | PFIZER ORD (CDI) |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
26.70 | 28.20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 58.5B | 2.12B | 0.3753 | 73.81 | 156.41B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
18:59:54 | O | 200 | 27.628 | USD |
Date | Time | Source | Headline |
---|---|---|---|
01/5/2024 | 13:42 | ALNC | TOP NEWS: Pfizer profit declines on lower Covid-related sales |
23/4/2024 | 06:27 | ALNC | Moderna, Pfizer/BioNTech set for UK court clash over Covid jab patents |
09/4/2024 | 18:41 | ALNC | Pfizer RSV treatment meets targets in trial of adults under age 60 |
21/3/2024 | 16:29 | ALNC | TOP NEWS: Haleon buys back shares worth GBP315 million from Pfizer |
19/3/2024 | 10:17 | ALNC | Haleon to buy back shares from Pfizer for GBP315 million |
18/3/2024 | 08:47 | ALNC | TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon |
13/3/2024 | 16:28 | ALNC | IN BRIEF: EU approves Pfizer's Prevenar in children with pneumococcal |
01/3/2024 | 18:27 | ALNC | Pfizer targets eight blockbuster drugs by 2030 in new oncology plan |
30/1/2024 | 12:56 | ALNC | TOP NEWS: Pfizer backs outlook but 2023 profit falls after Covid boost |
29/1/2024 | 08:26 | ALNC | Astellas and Pfizer's Padcev validated by EMA to treat bladder cancer |
Pfizer (0Q1N) Share Charts1 Year Pfizer Chart |
|
1 Month Pfizer Chart |
Intraday Pfizer Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2024-05-02 18:10:41 | 27.66 | 2 | 0.00 | O |
2024-05-02 18:10:27 | 27.66 | 7 | 0.00 | O |
2024-05-02 18:09:40 | 27.65 | 5 | 0.00 | O |
2024-05-02 18:07:11 | 27.64 | 108 | 0.00 | O |
2024-05-02 18:05:57 | 27.64 | 10 | 0.00 | O |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions